SCHEMBL11536407

SCHEMBL11536407

CC(C(=O)N=C(N)N)N1[C@@H](C)C=C[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11536395 1.00
SCHEMBL10913089 0.71 ALDH1A1 (0.34)
SCHEMBL10913085 0.71 ALDH1A1 (0.34)
SCHEMBL5696108 0.65
Rolgamidine SCHEMBL10909853 0.64 BACE1 (0.40)
Rolgamidine SCHEMBL10912462 0.64 BACE1 (0.40)
SCHEMBL7083160 0.56 TSHR (0.42)
SCHEMBL19426797 0.52
Acetylguanidinium SCHEMBL79063 0.51
SCHEMBL23278004 0.50 HRH3 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4140793-A HYPOGLYCEMIC AGENTS, ANTIULCER AGENTS JOHN WYETH & BROTHER, LTD. (GB) 1979-02-20 US claimed
US-4140793-A HYPOGLYCEMIC AGENTS, ANTIULCER AGENTS JOHN WYETH & BROTHER, LTD. (GB) 1979-02-20 US disclosed